China Hot Sales CAS 151767-02-1 Montelukast sodium singulair mk-476

Montelukast sodium is an oral and effective selective leukotriene receptor antagonist, which can specifically inhibit cysteinyl leukotriene receptors. It was successfully developed by Merck of Germany. In 1997, it was launched in Canada, Finland, Available in Mexico. It is suitable for the prevention and long-term treatment of asthma in adults and children, including the prevention of daytime and nighttime asthma symptoms, the treatment of aspirin-sensitive asthma patients, and the prevention of exercise-induced bronchoconstriction. Symptoms of seasonal allergic rhinitis in ineffective or intolerant patients.